Roche Revives Patent For Heart Risk Monitor At EPO
Roche has won a second chance at defending its patent for predicting heart failure, after an appellate board found that an earlier cardiac-screening study didn't undermine its intellectual property because it...To view the full article, register now.
Already a subscriber? Click here to view full article